ŸÀÌƲ¸í

19 Oct. (Fri.);
Annual Meeting of Korean Society for Transplantation (KST)

Time Room 1 Room 2 Room 3 Exhibition Room
08:00-08:30 Registration Poster presentation
(KST)
08:30-08:40 Opening Ceremony, KST  
08:40-09:40 KST Report; Research Grant  
09:40-10:30 Plenary Lecture  
10:30-11:00 Coffee break
11:00-12:00 Concurrent Symposium I (Kidney) Concurrent Symposium I I(Liver) Concurrent Symposium III (Pathology)
12:00-12:30     General Assembly (KST)
12:30-13:30 Luncheon symposium I (by CKD) Luncheon symposium II (by Roche)  
13:30-14:45 Free-Paper 1 (Kidney) Free-Paper 2 (Liver) Free-Paper 3 (Basic)
14:45-15:00 Coffee Break
15:00-16:15 Free-Paper 4 (Kidney) Free-Paper 5 (Liver) Free-Paper 6 (Lung-Heart)
16:15-16:30 Coffee Break
16:30-17:30 KST consensus Symposium  
17:30-18:30 Cocktail Party  
18:30 - Dinner Symposium (by Astellas)
Welcome Reception, KJTF
 

20 Oct. (Sat.);
Korea-Japan Transplantation Forum 2012 (AM)
Annual Meeting of Korean Society for Transplantation (KST)(PM)

Time Room 1 Room 2 Room 3 Exhibition Room
07:30- Registration Poster presentation
(KJTF 2012)
07:50-08:00 Opening Ceremony, KJTF  
08:00-09:20 KJTF 2012 Symposium  
09:20-09:40 Coffee Break
09:40-11:00 Free paper session
- Kidney
Free paper session
-Liver
Free paper session
-Basic & Others
11:00-12:20 Free paper session
- Kidney
Free paper session
-Liver
Free paper session
-Basic & Others
12:20-12:30 Break
12:30-13:30 Luncheon symposium III (by Novartis)
13:30-14:30 KST Report; Study Abroad Scholarship Free-Paper 7 (Basic)
14:30-14:45 Coffee Break
14:45-16:00 Free-Paper 8 (Kidney) Free-Paper 9 (Liver) Free-Paper 10 (Coordinator)
16:00-16:15 Coffee Break  
16:15-17:30 Free-Paper 11 (Kidney) Free-Paper 12 (Liver) Coordinator Symposium/
General Assembly
17:30-18:00 Awards Ceremony  
18:00- Closing  

¼¼ºÎÀÏÁ¤-10¿ù 19ÀÏ(±Ý)

08:30~08:40 °³È¸»ç ¼­º¸¾ç (¿µ³²ÀÇ´ë)
08:40~09:40 Grants Presentation(¿¬±¸ºñ)
ÁÂÀå : ¼­º¸¾ç (¿µ³²ÀÇ´ë) Á¶¹éȯ (ÀüºÏÀÇ´ë)
08:40~08:55 Immunologic Monitoring of T-lymphocyte Subsets and HLA-DR Positive Monocyte in Kidney Transplant Recipients ±èÂù´ö(°æºÏÀÇ´ë)
08:55~09:10 Analysis of S Gene Mutation of Hepatitis B Virus in Adult Liver Transplant Recipients showing Resistance to Prophylactic Therapy Using High-dose Hepatitis B Immunoglulin ¹®´öº¹(¿ï»êÀÇ´ë)
09:10~09:25 Effect of CXCR3 Polymorphisms on Graft Outcomes in Kidney Transplantation Çã±ÔÇÏ(¿¬¼¼ÀÇ´ë)
09:25~09:40 ³ú»çÀå±â±âÁõ È°¼ºÈ­¸¦ À§ÇÑ ÀÇ·áÀÎ ±³À° ±³Àç ¹ß°£ ¹Î»óÀÏ(¼­¿ïÀÇ´ë)
09:40~10:30 Plenary Lecture
ÁÂÀå : ÀÌ½Â±Ô (¿ï»êÀÇ´ë), ¹®Àμº (°¡Å縯ÀÇ´ë)
Use of ECMO for uncontrolled (Maastricht classification I) DCD donors
Shawn J. Pelletier (University of Michigan Health Systems)
10:30~11:00 Coffee Break
11:00~12:00 Concurrent Symposium I :
Kidney Transplantation Concurrent Session Antibodies and B cells in kidney transplantation
ÁÂÀå : ÇÑ´öÁ¾ (¿ï»êÀÇ´ë) ¹Ú¸íÈñ (¼­¿ïÀÇ´ë)
11:00~11:20 Role of B cell in allograft injury and clinical tolerance ÀÌÁ¾¼ö(¿ï»êÀÇ´ë)
11:20~11:40 Update in treatment of acute and chronic antibody mediated rejection ¹Ú°üÅÂ(°í·ÁÀÇ´ë)
11:40~12:00 Antibody to Minor HLA antigens in acute and chronic allograft rejection ¼ÛÀº¿µ(¼­¿ïÀÇ´ë)
11:00~12:00 Concurrent Symposium II :
Liver Transplantation Concurrent Session Liver Transplantation in Hepatitis C
ÁÂÀå : À̼®±¸ (¼º±Õ°üÀÇ´ë) ±è¼øÀÏ (¿¬¼¼ÀÇ´ë)
11:00~11:20 °£ÀÌ½Ä ¼ö¼ú Àü C Çü °£¿°ÀÇ °ü¸® ¹× Ç×¹ÙÀÌ·¯½º ¾àÁ¦ÀÇ ¼±Åà ¹è½ÃÇö(°¡Å縯ÀÇ´ë)
11:20~11:40 Management and immunosuppression for HCV after Liver Transplantation À̱¤¿õ(¼­¿ïÀÇ´ë)
11:40~12:00 Liver transplantation and retransplantation for patients with hepatitis C virus- associated diseases and hepatocellular carcinoma Ȳ ½Å(¿ï»êÀÇ´ë)
11:00~12:00 Concurrent Symposium III :
Pathology Concurrent Session
ÁÂÀå : 䵿¿Ï (¼­¿ïÀÇ´ë) Á¤ÇöÁÖ (¿¬¼¼ÀÇ´ë)
11:00~11:15 Introduction of renal transplantation pathology ±è¿ëÁø(¿µ³²ÀÇ´ë)
11:15~11:30 Pathologic updates on Antibody Mediated Rejection ÃÖ¿µÁø(°¡Å縯ÀÇ´ë)
11:30~11:45 T-cell-mediated rejection with an emphasis on acute vascular rejection Á¶¿µ¹Ì(¿ï»êÀÇ´ë)
11:45~12:00 Non-immunologic allograft failure ¹®°æö(¼­¿ïÀÇ´ë)
12:00~12:30 Á¤±âÃÑȸ
12:30~13:30 Luncheon Symposium I,II(Á¾±Ù´ç, ·Î½´)
13:30~14:45 ÀÚÀ¯¿¬Á¦ 1 : Kidney ÁÂÀå : À̻■ (ÇѸ²ÀÇ´ë) ±è¿µÈÆ (ÀÎÁ¦ÀÇ´ë)
13:30~13:42 Determination of rituximab dose according to immunologic risk in ABO incompatible KT ¾È°ÇÈñ(°¡Å縯ÀÇ´ë)
13:42~13:54 ABO-incompatible living-donor kidney transplantation using low-dose tacrolimus Çã±ÔÇÏ(¿¬¼¼ÀÇ´ë)
13:55~14:07 Single center experience of ABO incompatible kidney transplantation ±è¿µÈÆ(¿ï»êÀÇ´ë)
14:07~14:19 Significance of isoagglutinin titer in ABO-incompatible kidney transplantation ±Ç¼®¿î(¿ï»êÀÇ´ë)
14:20~14:32 Single center experience of flowcytometry crossmatch positive kidney Transplantation ±è¿µÈÆ(¿ï»êÀÇ´ë)
14:32~14:44 Antibody-Mediated Rejection In Pediatric kidney Allograft Recipients; A Risk Factor Analysis ÀÌÁö¿ø(¼­¿ïÀÇ´ë)
13:30~14:45 ÀÚÀ¯¿¬Á¦ 2 : Liver ÁÂÀå : ä±Ç¹¬ (¿ø±¤ÀÇ´ë) ÃÖÁø¼· (¿¬¼¼ÀÇ´ë)
13:30~13:42 The 'ABO cross-transplant problem' in liver transplantation ¹Ú¹Î¼ö(¼­¿ïÀÇ´ë)
13:42~13:54 Short-term Outcome of ABO-incompatible Adult Living Donor Liver Transplantation ±èÁ¾¸¸(¼º±Õ°üÀÇ´ë)
13:55~14:07 Renal function-based determination of mycophenolate dose for monotherapy in stable liver recipients ¹Ú¿äÇÑ(¿ï»êÀÇ´ë)
14:07~14:19 Use of generic mycophenolate for conversion maintenance therapy in stable liver Recipients Ȳ ½Å(¿ï»êÀÇ´ë)
14:20~14:32 Outcome of Liver Retransplantation: Analysis of a 24-Year Experience in a Single Center ±èÇý¿µ(¼­¿ïÀÇ´ë)
14:32~14:44 Familial heterozygous living donor liver transplantation ÃÖ¿µ·Ï(¼­¿ïÀÇ´ë)
13:30~14:45 ÀÚÀ¯¿¬Á¦ 3 : Basic and Kidney ÁÂÀå : ±èº´Ã¢ (¸Þ¸®³îº´¿ø) ±è¿¬¼ö(¼­¿ïÀÇ´ë)
13:30~13:45 Protective effect of Korean red ginseng on chronic cyclosporine-induced renal and pancreatic injury ÀÓ¼±¿ì(°¡Å縯ÀÇ´ë)
13:45~14:00 Intrarenal activation of IL-7 in acute rejection after kidney transplantation ÀÌ»óÈ£(°æÈñÀÇ´ë)
14:00~14:15 Comparison of QuantiFERON-TB Gold with Tuberculin Skin Test for Detecting Latent Tuberculosis Infection before Kidney Transplantation ±èÁؼ·(°æºÏÀÇ´ë)
14:15~14:30 Effects of Vitamin D and Bisphosphonate on Bone Mineral Density in Kidney Transplant Recipients ÀüÇýÁß(¼­¿ïÀÇ´ë)
14:30~14:45 Contrast Enhanced MR angiography and MR imaging in the Early Period After Kideny transplantation ±èÁöÀÏ(°¡Å縯ÀÇ´ë)
14:45~15:00 Coffee Break
15:00~16:15 ÀÚÀ¯¿¬Á¦ 4 : Kidney ÁÂÀå : Çã±æ (ºÀ»ýº´¿ø) ±è¼ºÈ¯ (Á¶¼±ÀÇ´ë)
15:00~15:12 Clinical Significance of protocol biopsy at three months after Kidney transplantation È«À¯¾Æ(°¡Å縯ÀÇ´ë)
15:12~15:24 The Impact of Time-zero Biopsy in Living Donor Kidney Transplantation for Early Graft Outcomes À̾ƶõ(¿¬¼¼ÀÇ´ë)
15:25~15:37 Significant of Time-zero Biopsy in Deceased Donor Kidney Transplant À̾ƶõ(¿¬¼¼ÀÇ´ë)
15:37~15:49 Effects of Switching from Prograf¢ç to Advagraf¢ç in Stable Pediatric Kidney Transplant Recipient ¹Î»óÀÏ(¼­¿ïÀÇ´ë)
15:50~16:02 Therapeutic Equivalence of Generic Tacrolimus Formulation in De Novo Kidney Transplant recipients ¹Î»óÀÏ(¼­¿ïÀÇ´ë)
16:02~16:14 Long-term outcome of mycophenolate mofetil versus azathioprine in a cyclosporine- based immunosuppression in kidney transplant: 10 years experience at single center ±Ç¿À¾ð(°æºÏÀÇ´ë)
15:00~16:15 ÀÚÀ¯¿¬Á¦ 5 : Liver ÁÂÀå : ÃÖµ¿¶ô (´ë±¸°¡Å縯ÀÇ´ë) ÃÖ¹®¼® (¼º±Õ°üÀÇ´ë)
15:00~15:12 Analysis of Predictive Value of MELD Score for Patient Survival in LDLT ÁÖµ¿Áø(¿¬¼¼ÀÇ´ë)
15:12~15:24 Comparison of KONOS Status with MELD score À̼öÇü(¿¬¼¼ÀÇ´ë)
15:25~15:37 The Uneven Distribution of Fat in the liver ÃÖ¿µ·Ï(¼­¿ïÀÇ´ë)
15:37~15:49 »ýü°£ÀÌ½Ä ±âÁõÀÚ·Î µî·ÏÇÑ ±âÁõ¿¹Á¤ÀÚÀÇ °æ°ú¿¡ °üÇÑ °íÂû ±è¿Á°æ(¼­¿ïÀÇ´ë)
15:50~16:02 Prophyaxis and preemptive therapy for CMV infection after liver transplantation in CMV endemic area Áö¿õ¹è(°í·ÁÀÇ´ë)
16:02~16:14 Strategies to reduce infectious complications using epidemiologic data analysis in liver transplant recipients ±è»óÀÏ(°¡Å縯ÀÇ´ë)
15:00~16:15 ÀÚÀ¯¿¬Á¦ 6 : Heart, Lung, Organ Donation ÁÂÀå : ¹éȿä (¿¬¼¼ÀÇ´ë) ±èÀçÁß (¿ï»êÀÇ´ë)
15:00~15:15 ÆóÀ̽Ŀ¡¼­ ü¿Ü Æó °ü·ù ¸ðµ¨ÀÇ Àû¿ë ÇÔ¼®Áø(¿¬¼¼ÀÇ´ë)
15:15~15:30 The efficacy of everolimus to prevent cardiac allograft vasculopathy in patients with heart transplantation; comparison with cyclosporine-based and tacrolimus-based protocols ±èÀçÁß(¿ï»êÀÇ´ë)
15:30~15:45 ¼Ò¾Æ¿¬·É¿¡¼­ÀÇ ½ÉÀåÀ̽ļö¼ú ¹ÚÇѱâ(¿¬¼¼ÀÇ´ë)
15:45~16:00 º¹ºÎ ´ÙÀå±â ÀÌ½Ä – ±¹³» ÃÖÃÊ º¸°í ±è´ë¿¬(¿ï»êÀÇ´ë)
16:00~16:15 Evaluation of the KONOS expanded donor criteria in deceased donor renal Transplantation ¹ÚÀÇÁØ(°è¸íÀÇ´ë)
16:15~16:30 Coffee Break
16:30~17:30 Satellite Symposium :
ABO incompatible KT consensus meeting
ÁÂÀå : ±èÀ¯¼± (¿¬¼¼ÀÇ´ë) ¹Ú¼ö±æ (¿ï»êÀÇ´ë)
16:30~16:45 Çѱ¹ÀÇ ABO ºÎÀûÇÕ »ýü ½ÅÀåÀ̽Ä(ABOi KT) °øÁø¹Î (BHSÇѼ­º´¿ø)
16:45~17:00 Adult ABO Incompatible Living Donor Liver Transplantation in Korea ¿ÕÈñÁ¤ (¾ÆÁÖÀÇ´ë)
17:00~17:15 Ç÷¾×Çü ºÒÀÏÄ¡ ½ÅÀå ÀÌ½Ä °ü·Ã ÃÖ±Ù À̽´ ¾çö¿ì(°¡Å縯ÀÇ´ë)
17:15~17:30 Panel Discussion
17:30~18:30 Cocktail party
18:30~ Dinner Symposium and Welcome Reception (Astellas)

¼¼ºÎÀÏÁ¤-10¿ù 20ÀÏ(Åä)

07:50~08:00 Opening remarks Won Hyun Cho (Keimyung Univ.)
08:00~09:20 KJTF 2012 Plenary session :
Strategy for increasing transplant activity
Moderator : Yonson Ku(Kobe Univ.), Won Hyun Cho (Keimyung Univ.)
08:00~08:20 Obstacles of successful donation after cardiac death-Japanese side Kazuhide Saito (Niigata Univ.)
08:20~08:40 Progresses and challenges in improving organ donation-Korean side Jong Won Ha (Seoul Univ)
08:40~09:00 Expansion of donor sources. Hurdles of xenotransplantation Takaaki Kobayashi (Nagoya Univ)
09:00~09:20 Exchange donor program vs. ABO incompatible transplantation Myoung Soo Kim (Yonsei Univ)
09:20~09:40 Coffee Break
09:40~11:00 Free paper 1 : Kidney Moderator : Kazunari Tanabe(Tokyo Women's Medical Univ.), Oh Jung Kwon (Hanyang Univ)
09:40~09:51 Clinical Impact of Pretransplant HLA-DQ Donor-Specific Antibodies in Kidney Transplantation Sang-Il Min(Seoul National Univ.)
09:51~10:02 The clinical study of immunosuppression protocol in ABO-incompatible kidney transplantation Masahiro Ikeda(Niigata Univ.)
10:02~10:13 Efficacy of Early Steroid Withdrawal with Anti-Thymocyte Globulin Induction Young Hoon Kim(Ulsan Univ.)
10:14~10:25 Excellent results of both T and B cell FCXM positive cases in living donor kidney transplantation. Soshi Terasaka(Sciences Kyushu Univ.)
10:25~10:36 Decreased Klotho expression is associated with persistent hyperparathyroidism after KT Yu ah Hong(The Catholic Univ.)
10:36~10:47 Beneficial Effects of Tonsillectomy in Kidney Transplant Patients with Recurrent IgA Nephropathy Naotsugu Ichimaru(Osaka Univ.)
10:48~10:59 Change of risk factors affecting renal allograft survival by transplant era Lee A-Lan(Yonsei Univ.)
09:40~11:00 Free paper 2 : Liver Moderator : Susumu Eguchi(Nagasaki Univ.), Kyung-Suk Suh (Seoul Univ.)
09:40~09:51 Usefulness of alpha-fetoprotein and C-reactive protein as preoperative markers of prognosis in patients with hepatocellular carcinoma after living donor liver transplantation Shozo Mori(Dokkyo Medical Univ.)
09:51~10:02 Tumor pathology at the time of primary liver resection is associated with recurrence of hepatocellular carcinoma after salvage liver transplantation: a multicenter analysis of 82 cases Sanghoon Lee(Sungkyunkwan Univ.)
10:02~10:13 The outcomes of patients with severe hyperbilirubinemia following living donor liver transplantation Hajime Matsushima(Nagasaki Univ.)
10:14~10:25 Outcome of various treatments for post-transplant hepatitis B virus Recurrence Nam-Joon Yi (Seoul National Univ.)
10:25~10:36 Peripheral blood marker for acute cellular rejection in liver transplantation. Naoki Hama(Osaka Univ.)
10:36~10:47 S gene mutation of hepatitis B virus in liver transplant recipients showing HBIG Resistance Gil-Chun Park(Ulsan Univ.)
10:48~10:59 Fragility Index, A Novel Predictor to Assess CKD after Living Donor Liver Transplantation Kaori Kuramitsu(Kobe Univ.)
09:40~11:00 Free paper 3 : Basic and Other Moderator : Takashi Kenmochi(Fujita Health Univ.), Chul Woo Yang (Catholic Univ.)
09:40~09:51 Multi-photon microscopy-based kidney live imaging in a rat acute kidney rejection Model Junya Kaimori(Osaka Univ.)
09:51~10:02 Islet allograft rejection in sensitized mice is refractory to combination of immune- modulating agent Tai Yeon Koo(Seoul National Univ.)
10:02~10:13 The Effect of Adipose Derived Mesenchymal Stem Cell for the Tolerance and Treg Role in vitro Study Jong won HONG(Yonsei Univ.)
10:14~10:25 Impact of the flowcytemetric crossmatch B-cell positive in living renal transplantation Kei Kurihara(Hidehisa Kitada)
10:25~10:36 False-positive T-NIH cytotoxicity test results due to autoantibodies in KONOS crossmatch tests Hyewon Park(Seoul National Univ.)
10:36~10:47 Outbreak of Pneumocystis Pneumonia in Long-Term Renal Transplant Recipients Atsushi Aikawa(Toho Univ.)
10:48~10:59 A case of everolimus-associated chylothorax in a cardiac transplant recipient Norihide Fukushima(Osaka Univ.)
11:00~12:20 Free paper 4 : Kidney Moderator : Kenji Yuzawa (National Hospital Organization Mito Medical Center), Ik Jin Yun(Konkuk Univ.)
11:00~11:11 Late-onset neutropenia after low-dose rituximab treatment. Mr Hideki ISHIDA(TWMU)
11:11~11:22 Successful Withdrawal of Antiviral Therapy in Kidney Transplants with Chronic Hepatitis B infection Jang Hee Cho(Kyungpook National Univ.)
11:22~11:33 Banff Working Proposal for Polyomavirus BK nephropathy Kosuke Masutani(Kyushu Univ.)
11:34~11:45 High Pre-transplant Hepatitis B Virus (HBV) Level Predicts HBV Reactivation after Kidney Transplantation in HBV Infected Recipients Jong Man Kim(Sungkyunkwan Univ.)
11:45~11:56 The Fate of 527 Renal Allografts Retrieved from Donors after Cardiac Death (Fujita Experience) Mamoru Kusaka(Fujita-Health Univ.)
11:56~12:07 The influences of pregnancy on renal function of women with allograft kidney in peripartum period Hyosang Kim(Ulsan Univ.)
11:08~11:19 Outcomes of Retroperitoneoscopic Procurement of Kidneys with Multiple Renal Arteries. Kazuya Omoto(Tokyo Women's Medical Univ.)
11:00~12:20 Free paper 5 : Liver Moderator : Hiroaki Nagano (Osaka Univ.), Jae Won Joh (Sungkyunkwan Univ.)
11:00~11:11 Role of hand-assisted laparoscopic surgery (HALS) for living donor right lobe harvest Tae-Yong Ha(Ulsan Univ.)
11:11~11:22 A hybrid procedure of laparoscopic-assisted open liver resection in living donor Hetapectomy MItsuhisa Takatsuki(Nagasaki Univ.)
11:22~11:33 Does procurement technique affect posttransplant graft function in DDLT? Sung Won Jung(Korea Univ.)
11:34~11:45 An experience of hemitransposition for a patient with a massive thrombus of the portal trunk and SMV Ryuji Sakuyama(Tokyo Womens' Medical Univ.)
11:45~11:56 The choice of the right or left hepatic artery in right lobe living donor liver Transplantation Young Seok Han(Daegu Catholic univ.)
11:56~12:07 Living donor liver transplantation with alternative porto-left gastric vein anastomosis in patients with post-Kasai extrahepatic portal vein obstruction Toshihiro Kitajima(National Center for Child Health and Development)
11:08~11:19 Graft function measured by transient elastography in living donor liver transplantation Su Hyung Lee(Yonsei Univ.)
11:00~12:20 Free paper 6 : Basic and Other Moderator : Tetsuya Kiuchi(Nagoya Univ.), Curie Ahn (Seoul Univ.)
11:00~11:11 Mycophenolic acid regulates Sky to repress TNF¥á-induced MCP-1 production in aortic endothelial cell Tai Yeon Koo(Seoul National Univ.)
11:11~11:22 Inhalation of hydrogen reduced ischemia/reperfusion lung injury through heme oxygenase-1 induction Tomohiro Kawamura(Osaka Univ.)
11:22~11:33 Current outcome of deceased donor pancreas/pancreas-kidney transplantation in Japan Taihei Ito(Fujita-Health Univ.)
11:34~11:45 Japanese strategies for maximizing lung availabilities: Experience from 100 consecutive donation Norihide Fukushima(Osaka Univ.)
11:45~11:56 Analysis of the processing time from the brain death to transplantation for the face Transplantation Jong won HONG(Yonesei Univ.)
11:56~12:07 A case of strongly suspected acute GVHD following simultaneous pancreas-kidney Transplant Sadaki Asari(Kobe Univ.)
11:08~11:19 Graft-versus-Host Disease (GVHD) following cadaveric kidney transplantation Yuhji MARUI(Toranomon Hospital Kajigaya)
12:30~13:30 Lunchen Symposium III (Novartis) - Certican
13:30~14:30 ÇØ¿Ü¿¬¼öÀåÇÐ±Ý º¸°í
ÁÂÀå : ¹Ú¼º±¤ (ÀüºÏÀÇ´ë)/±è¼®¿µ (°¡Å縯ÀÇ´ë)
13:30~13:45 The Living Donor Evaluation as a Life-Saving Event ¹Ú¼øö(°¡Å縯ÀÇ´ë)
13:45~14:00 Viral metagenomics in transplantation ±è¿µ¼ö(°¡Å縯ÀÇ´ë)
14:00~14:15 Clinical experience in intestinal transplantation ¾ÈÇüÁØ(°æÈñÀÇ´ë)
14:15~14:30 Natural IgM Anti-Leukocyte Autoantibodies(IgM-ALA) Block Immune Mediated Pro-inflammatory Cytokine Release through Inhibition of NF-kB Activation ÀÌ»óÁÖ(°¡Å縯ÀÇ´ë)
13:30~14:30 ÀÚÀ¯¿¬Á¦ 7 : Basic and Liver ÁÂÀå : ±è¼ºÁÖ (¼º±Õ°üÀÇ´ë) ¹ÚÁ¤±Ô (¼­¿ïÀÇ´ë)
13:30~13:42 Drug interaction between TAC and EVR in chronic TAC-induced nephrotoxicity and pancreatic injury Shang Guo Piao(°¡Å縯ÀÇ´ë)
13:42~13:54 Prognostic value of pretransplant peripheral blood monocyte count in patients undergoing liver transplantation for hepatocellular carcinoma ±è¿µ±Ô(±¹¸³¾Ï¼¾ÅÍ)
13:54~14:06 Do Donor Specific Antibodies Affect Graft Liver Outcomes in LDLT? ÁÖµ¿Áø(¿¬¼¼ÀÇ´ë)
14:06~14:18 Significant Donor Hyporesponsiveness in Pediatric Patients Over 3 years After LTLD °­Àº¼÷(¼­¿ïÀÇ´ë)
14:18~14:30 Perioperative AFP Levels: Useful Markers Predicting Prognosis of Hepatocellular carcinoma Patients À¯Å¼®(¼­¿ïÀÇ´ë)
14:30~14:45 Coffee Break
14:45~16:00 ÀÚÀ¯¿¬Á¦ 8 : Kidney ÁÂÀå : ±èÁß°æ (ºÀ»ýº´¿ø) Á¶È«·¡ (¿ï»êÀÇ´ë)
14:45~14:57 Comparison between CKD-EPI and MDRD equation in the estimation of renal function in kidney donors Á¤º´ÇÏ(°¡Å縯ÀÇ´ë)
14:57~15:09 Infectious complications associated with desensitization in kidney transplant Recipients À̸íÇö(°¡Å縯ÀÇ´ë)
15:10~15:22 Risk factors for recurrent urinary tract infection in kidney transplant recipients ÀÓÁ¤ÈÆ(°æºÏÀÇ´ë)
15:22~15:34 Monitoring and Treatment of BK virus infection in Kidney Transplantation ¹®Çüȯ(¼º±Õ°üÀÇ´ë)
15:35~15:47 The clinical courses of renal transplant recipients with high BK viremia ±èÈ¿»ó(¿ï»êÀÇ´ë)
15:47~15:59 Impact of Combined Acute Rejection on BK Virus-Associated Nephropathy in kidney Transplantation ±èÀ±Á¤(¼­¿ïÀÇ´ë)
14:45~16:00 ÀÚÀ¯¿¬Á¦ 9 : Liver ÁÂÀå : ±èÁÖ¼· (ÇѸ²ÀÇ´ë) ÃÖÁ¾¿µ (°¡Å縯ÀÇ´ë)
14:45~14:57 Outcomes of liver transplantation for combined hepatocellular carcinoma and Cholangiocarcinoma ¹Ú¿äÇÑ(¿ï»êÀÇ´ë)
14:57~15:09 LDLT after neoadjuvant concurrent chemoradiation therapy combined with multimodal treatment for HCC ÇÑ´ëÈÆ(¿¬¼¼ÀÇ´ë)
15:10~15:22 The outcome of liver transplantation for combined hepatocellular- cholangiocarcinoma patient ¼Û»óÇö(¼º±Õ°üÀÇ´ë)
15:22~15:34 Small for size living donor graft showed higher incidence of hepatocellular carcinoma recurrence ¹Ú¹Î¼ö(¼­¿ïÀÇ´ë)
15:35~15:47 Liver Transplantation in Lymphoma Patients with Hepatitis B Virus Reactivation ±èÁ¾¸¸(¼º±Õ°üÀÇ´ë)
15:47~15:59 Transarterial radioembolization (TARE) using Yttrium-90 microspheres for advanced Hepatocellular carcinoma prior to living donor liver transplantation : our experience of 3 cases À¯¿µµ¿(°í·ÁÀÇ´ë)
14:45~16:00 ÀÚÀ¯¿¬Á¦ 10 : Coordinator ÁÂÀå : ±è¸íÈñ (¿µ³²´ëÇб³º´¿ø) Àü°æ¿Á (¼¼ºê¶õ½ºº´¿ø)
14:45~15:03 °£À̽ÄȯÀÚÀÇ Áõ»ó°íÅë°¨, »çȸÀûÁöÁö, »îÀÇ Áú¿¡ °üÇÑ ¿¬±¸ Àü°æ¿Á(¼¼ºê¶õ½ºº´¿ø)
15:04~15:22 Change in donor quality of life after living donor kidney transplantation surgery ±èº¹³à(»ï¼º¼­¿ïº´¿ø)
15:23~15:41 °£ÀÌ½Ä È¯ÀÚÀÇ ¸é¿ª¾ïÁ¦Á¦ º¹¿ëÀÌÇà ½ÇÅ À̼±¿µ(¼¼ºê¶õ½ºº´¿ø)
15:42~16:00 ¼­¿ï¾Æ»êº´¿ø ÇìÆĺò(Hepatitis B Immunoglobulin) ÁÖ»çÇöȲ ¹× ÁÖ»ç¹æ¹ý °íÂû ÇÏÈñ¼±(¼­¿ï¾Æ»êº´¿ø)
16:00~16:15 Coffee Break
16:15~17:30 ÀÚÀ¯¿¬Á¦ 11 : Kidney ÁÂÀå : ±è¿ë¸² (°æºÏÀÇ´ë) ¿Àâ±Ç (¾ÆÁÖÀÇ´ë)
16:15~16:27 The Intermediate-Term outcomes of Renal Transplantation with Expanded Criteria Deceased Donors ±èÁöÀÏ(°¡Å縯ÀÇ´ë)
16:27~16:39 Outcomes of expanded criteria-deceased donor kidney transplantation in a single Korean center Çѹ̿¬(¼­¿ïÀÇ´ë)
16:40~16:52 The initial results of the DDKT from the new kidney transplantation center ¹®ÁÖÀÍ(°Ç¾çÀÇ´ë)
16:52~17:04 Risk factors and clinical outcomes for delayed graft function with deceased donor renal transplant ±èÁöÀÏ(°¡Å縯ÀÇ´ë)
16:05~16:17 Hand-Assisted Laparoscopic Donor Nephrectomy Using Low Transverse Incision for the Hand-Assist Port : comaparative outcome of hand-assisted laparoscopic donor nephrecotmy using midline incision and low transverse incision (Video Presentation) Á¤Ã¶¿õ(°í·ÁÀÇ´ë)
16:17~16:29 Can shear wave velocity of donor kidney predict graft function after transplantation? À̾ƶõ(¿¬¼¼ÀÇ´ë)
16:15~17:30 ÀÚÀ¯¿¬Á¦ 12 : Liver ÁÂÀå : À¯¿µ°æ (°¡Å縯ÀÇ´ë) °­±¸Á¤ (°è¸íÀÇ´ë)
16:15~16:27 Middle hepatic vein reconstruction by using Dacron graft in right lobe living donor liver transplantation ÇÑ¿µ¼®(´ë±¸°¡Å縯ÀÇ´ë)
16:27~16:39 Left hepatic vein anatomy and venoplasty techniques for pediatric living donor liver Transplantation Ȳ½Å(¿ï»êÀÇ´ë)
16:40~16:52 Small for size living donor graft showed higher incidence of hepatocellular carcinoma recurrence ¹Ú¹Î¼ö(¼­¿ïÀÇ´ë)
16:52~17:04 Single center experience of liver transplantation in patients with portal vein Thrombosis ¼Û»óÇö(¼º±Õ°üÀÇ´ë)
16:05~16:17 LDLT after Inferior Vena Cava Replacement using Artificial Vascular Graft in Cirrhotic and Advanced Hepatocellular carcinoma (Video presentation) ¹®´öº¹(¿ï»êÀÇ´ë)
16:17~16:29 Salvage dual LDLT for HCC after major hepatectomy ±èÁÖµ¿(´ë±¸°¡Å縯ÀÇ´ë)
16:15~17:30 Coordinator Symposium
ÁÂÀå: º¹ÃáÈñ(Çѱ¹Àå±â±âÁõ¿ø)/È«Á¤ÀÚ(¼­¿ï¾Æ»êº´¿ø)
16:15~16:40 Àå±âÀÌ½Ä ÈÄ °¨¿° °ü¸® ¹ÚÀº¼÷(¼¼ºê¶õ½ºº´¿ø)
16:40~17:05 ÃéÀå À̽İú Ãéµµ ÀÌ½Ä ¹ÚÀç¹ü(¼º±Õ°üÀÇ´ë)
17:05~17:30 ÃÑȸ
17:30~18:00 Awards Ceremony
18:00~ Æóȸ
Copyright 2004 The Korean Society of transplantation. All Rights Reserved.
120-752 ¼­¿ï½Ã ¼­´ë¹®±¸ ¿¬¼¼·Î50 ¿¬¼¼ÀÇ´ë ·¯µé·Î±³¼öµ¿ 2Ãþ ¿Ü°úÇб³½Ç ³» Tel: 02-484-8052 / Fax: 02-485-8052 / E-mail: ksot@chol.com